UK-based digital diagnostics platform Bloodtest.co.uk has secured a £3 million investment from an American private equity group, in exchange for a 20 per cent equity stake, valuing the company at £15 million.
The £3 million investment will be used to enhance the Bloodtest.co.uk digital platform, expand its diagnostics offering and accelerate user acquisition through targeted marketing
The company will also seek to build commercial partnerships with healthcare providers, insurers and employers.
The platform is designed to give individuals fast, direct access to blood tests — with results and personalised insights delivered securely online, bypassing long wait times and unnecessary appointments in traditional healthcare settings.
Giles Meadows, Founder of Bloodtest.co.uk, said: “This is a huge moment for us.
“It’s been many months in the making to secure this investment, and it’s encouraging to work with people who understand where we want to position the company.
“Their belief in our mission and approach means a lot — this is just the beginning.”
Bloodtest.co.uk is a UK-based digital health platform offering direct access to private blood testing.
The service enables individuals to book blood tests online, attend a local clinic, or arrange a home visit, and receive results with medical commentary — all without requiring a GP referral.
The business aims to simplify access to essential health data in an increasingly digital-first healthcare environment.
A spokesperson for the American investment group said: “We’re seeing sustained growth in demand for private healthcare services, particularly in markets like the UK, where innovation is reshaping access and delivery.
“What impressed us about Bloodtest.co.uk was not only its market traction but also the strength of its technical vision — especially the integration of AI-powered aftercare.
“This is a company solving real-world problems in a modern, scalable way, and we’re excited to support the next phase of its growth.”
